Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.

Xiaotao ZhangHashem B El-SeragAaron P Thrift

Published in: Cancer causes & control : CCC (2021)

Curative intent treatment was the strongest predictor for survival ≥ 5 years among HCC patients. Given the limited availability of liver transplant and limited eligibility for surgical resection, finding curative intent HCC therapies remain critically important.

Keyphrases

prognostic factors
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
rectal cancer
free survival
peritoneal dialysis
healthcare
patient reported outcomes
combination therapy
affordable care act